RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma

참고문헌 (39)

1. Llovet, J. M., "Hepatocellular carcinoma", Nat. Rev. Dis. Primers, 7, pp.6~ (2021)
2. Villanueva, A., "Hepatocellular carcinoma", New England J. Med, 380, pp.1450~1462 (2019)
3. Craig, A. J., "Tumour evolution in hepatocellular carcinoma", Nat. Rev. Gastroenterol. Hepatol, 17, pp.139~152 (2020)
4. Marrero, J. A., "Diagnosis, staging, and management of hepatocellular car cinoma : 2018 Practice Guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
5. Masuho, I., "A global map of G protein signaling regulation by RGS proteins", Cell, 183, pp.503~521 (2020)
6. Ahlers, K. E., "RGS6 as a novel therapeutic target in CNS diseases and cancer", AAPS J, 18, pp.560~572 (2016)
7. Riddle, E. L., "Multi-tasking RGS proteins in the heart: the next therapeutic target?", Circ. Res, 96, pp.401~411 (2005)
8. Huang, D., "Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer", Nat. Immunol, 22, pp.865~879 (2021)
9. Berman, D. M., "GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits", Cell, 86, pp.445~452 (1996)
10. Lou, X., "GIPC and GAIP form a complex with TrkA : a putative link between G protein and receptor tyrosine kinase pathways", Mol. Biol. Cell, 12, pp.615~627 (2001)
11. Tso, P. H., "RGS19 stimulates cell proliferation by deregulating cell cycle control and enhancing Akt signaling", Cancer Lett, 309, pp.199~208 (2011)
12. Hu, Y., "Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer", Genomics, 113, pp.2134~2144 (2021)
13. Hu, D., "Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients", J. Transl. Med, 18, pp.160~ (2020)
14. Liu, Y., "Genome-wide screening for the G-protein-coupled receptor(GPCR)pathway-related therapeutic gene RGS19(regulator of G protein signaling 19)in bladder cancer", Bioengineered, 12, pp.5892~5903 (2021)
15. Zhong, Y., "MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly", Cell Death Differ, 28, pp.3251~3269 (2021)
16. Lin, X., "Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma", Signal Transduct. Targeted Therapy, 5, pp.13~ (2020)
17. Singh, S. K., "MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment", Med. Oncol. (Northwood, London, England), 37, pp.88~ (2020)
18. Zhou, P., "NMIIA promotes tumor growth and metastasis by activating the Wnt", β-catenin signaling pathway and EMT in pancreatic cancer, 2019, pp.38, 5500~5515
19. Ye, G., "Nuclear MYH9-induced CTNNB1 transcription, targeted by staur osporin, promotes gastric cancer cell anoikis resistance and metastasis", Ther anostics, 10, pp.7545~7560 (2020)
20. Thompson, M. D., "WNT", beta-catenin signaling in liver health and disease, 2007, pp.45, 1298~1305
21. Monga, S. P., "β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis", Gastroenterology, 148, pp.1294~1310 (2015)
22. Vlad, A., "The first five years of the Wnt targetome", Cell. Signall, 20, pp.795~802 (2008)
23. Perugorria, M. J., "Wnt-β-catenin signalling in liver development, health and disease", Nat. Rev. Gastroenterol. Hepatol, 16, pp.121~136 (2019)
24. Dang, C. V., "c-Myc target genes involved in cell growth, apoptosis, and metabo lism", Mol. Cell. Biol, 19, pp.1~11 (1999)
25. Casey, S. C., "The MYC oncogene is a global regulator of the immune response", Blood, 131, pp.2007~2015 (2018)
26. Casey, S. C., "MYC : master regulator of immune privilege", Trends Immunol, 38, pp.298~305 (2017)
27. "Comprehensive and integrative genomic characterization of hepatocellular car cinoma", Cell, 169, pp.1327~1341 (2017)[DOI]
28. Roessler, S., "A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients", Cancer Res, 70, pp.10202~10212 (2010)
29. Ogier-Denis, E., "Erk1", 2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells, 2000, pp.275, 39090~39095
30. Dasgupta, S., "RGS5-TGFβ-Smad2", 3 axis switches pro-to anti-apoptotic sig naling in tumor-residing pericytes, assisting tumor growth, 2021, pp.28, 3052~3076
31. Li, C., "The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS", Science (New York, N.Y.), 374, pp.197~201 (2021)
32. Cho, J., "RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse", J. Clin. Invest, 131 (2021)[DOI]
33. Gao, S., "TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β", β-catenin signalling, 2022, pp.13, 2792~
34. Hu, S., "Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling", Cell Death Differ, 29, pp.642~656 (2022)
35. Li, Y., "circ-EIF6 encodes EIF6-224aa to promote TNBC progression via sta bilizing MYH9 and activating the Wnt", beta-catenin pathway, 2022, pp.30, 415~430
36. Mahlokozera, T., "Competitive binding of E3 ligases TRIM26 and WWP2controls SOX2 in glioblastoma", Nat. Commun, 12, pp.6321~ (2021)
37. Liu, L., "An RFC4", Notch1 signaling feedback loop promotes NSCLC metastasis and stemness, 2021, pp.12, 2693~
38. Shroff, E. H., "MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism", Proc. Natl Acad. Sci. USA, 112, pp.6539~6544 (2015)
39. Sodir, N. M., "MYC instructs and maintains pancreatic adenocarcinoma phenotype", Cancer Discov, 10, pp.588~607 (2020)

관련 논문AI추천